IN139006B - - Google Patents

Info

Publication number
IN139006B
IN139006B IN1864/CAL/73A IN1864CA1973A IN139006B IN 139006 B IN139006 B IN 139006B IN 1864CA1973 A IN1864CA1973 A IN 1864CA1973A IN 139006 B IN139006 B IN 139006B
Authority
IN
India
Application number
IN1864/CAL/73A
Other languages
English (en)
Inventor
B Gadsby
P Cross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IN139006B publication Critical patent/IN139006B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B31/00Disazo and polyazo dyes of the type A->B->C, A->B->C->D, or the like, prepared by diazotising and coupling
    • C09B31/02Disazo dyes
    • C09B31/12Disazo dyes from other coupling components "C"
    • C09B31/14Heterocyclic components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN1864/CAL/73A 1972-08-12 1973-08-13 IN139006B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3772072A GB1380009A (en) 1972-08-12 1972-08-12 Cyclic derivatives of 1,4-benzene disulphonamide

Publications (1)

Publication Number Publication Date
IN139006B true IN139006B (nl) 1976-04-24

Family

ID=10398552

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1864/CAL/73A IN139006B (nl) 1972-08-12 1973-08-13

Country Status (16)

Country Link
US (1) US3867390A (nl)
JP (2) JPS59508B2 (nl)
AT (1) AT331248B (nl)
AU (1) AU5908473A (nl)
BE (1) BE803373A (nl)
CA (1) CA978945A (nl)
DE (1) DE2340010A1 (nl)
ES (1) ES417806A1 (nl)
FR (1) FR2195449B1 (nl)
GB (1) GB1380009A (nl)
IE (1) IE38177B1 (nl)
IN (1) IN139006B (nl)
LU (1) LU68211A1 (nl)
NL (1) NL162641C (nl)
SE (1) SE385008B (nl)
ZA (1) ZA735474B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070361A (en) * 1977-04-21 1978-01-24 E. R. Squibb & Sons, Inc. Mercaptoalkylsulfonyl proline and pipecolic acid and esters thereof
DE2720654A1 (de) * 1977-05-07 1978-11-16 Bayer Ag Azolyl-alkancarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS5922023A (ja) * 1982-07-27 1984-02-04 Hoya Corp ビ−ムスプリツタ−

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165550A (en) * 1960-06-29 1965-01-12 Pfizer & Co C N-substituted p-benzenedisulfonamides

Also Published As

Publication number Publication date
LU68211A1 (nl) 1975-05-21
FR2195449B1 (nl) 1977-09-09
GB1380009A (en) 1975-01-08
AT331248B (de) 1976-08-10
NL162641C (nl) 1980-06-16
BE803373A (fr) 1974-02-08
ATA691573A (de) 1975-11-15
ZA735474B (en) 1974-08-28
JPS59508B2 (ja) 1984-01-07
JPS4985066A (nl) 1974-08-15
JPS57131774A (en) 1982-08-14
JPS5857431B2 (ja) 1983-12-20
NL7311000A (nl) 1974-02-14
DE2340010A1 (de) 1974-03-14
IE38177B1 (en) 1978-01-18
US3867390A (en) 1975-02-18
FR2195449A1 (nl) 1974-03-08
ES417806A1 (es) 1976-03-01
SE385008B (sv) 1976-05-31
AU5908473A (en) 1975-02-13
NL162641B (nl) 1980-01-15
IE38177L (en) 1974-02-12
CA978945A (en) 1975-12-02

Similar Documents

Publication Publication Date Title
AU465394B2 (nl)
FR2179117A1 (nl)
JPS5235562B2 (nl)
FR2195449B1 (nl)
JPS5043145Y2 (nl)
JPS5133670B2 (nl)
JPS528995Y2 (nl)
JPS534736Y2 (nl)
JPS4952863U (nl)
JPS4956932A (nl)
CH545959A (nl)
CH580625A5 (nl)
CH572056A5 (nl)
CH575380A5 (nl)
BG18427A1 (nl)
BG18542A1 (nl)
CH336274A4 (nl)
CH565266A5 (nl)
CH576294A5 (nl)
CH576369A5 (nl)
CH577576A5 (nl)
BG18378A1 (nl)
CH559500A5 (nl)
CH559551A5 (nl)
CH578118A5 (nl)